Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 0.6850
+0.0150 (2.24%)
Oct 2, 2026, 5:35 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €9.97 million as of October 2, 2026. Its market cap has decreased by -60.22% in one year.
Market Cap
9.97M
Enterprise Value
29.60M
Revenue
6.50M
Ranking
n/a
PE Ratio
231.75
Stock Price
€0.69
ChartMarket Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 9.97M, a decrease of -91.11%. That is a compound annual growth rate of -23.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 9.97M | -59.34% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 20.75M |
| GenSight Biologics | 20.49M |
| MaaT Pharma | 19.41M |
| Biophytis | 15.86M |
| Aelis Farma | 12.02M |
| TME Pharma | 9.69M |
| Aton | 9.61M |
| Poxel | 8.94M |